We serve Chemical Name:5-phenyl-5-propyl-1,3-diazinane-4,6-dione CAS:59026-31-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-phenyl-5-propyl-1,3-diazinane-4,6-dione
CAS.NO:59026-31-2
Synonyms:MFCD00006011;5-phenyl-5-propyl-dihydro-pyrimidine-4,6-dione;5-Phenyl-5-propyl-dihydro-pyrimidin-4,6-dion
Molecular Formula:C13H16N2O2
Molecular Weight:232.27800
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:521.3ºC at 760 mmHg
Density:1.115g/cm3
Index of Refraction:1.524
PSA:58.20000
Exact Mass:232.12100
LogP:1.58560
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00006011 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Phenyl-5-propyl-dihydro-pyrimidin-4,6-dion physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-phenyl-5-propyl-dihydro-pyrimidine-4,6-dione Use and application,5-Phenyl-5-propyl-dihydro-pyrimidin-4,6-dion technical grade,usp/ep/jp grade.
Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs. 5-phenyl-5-propyl-1,3-diazinane-4,6-dione manufacturer Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs. 5-phenyl-5-propyl-1,3-diazinane-4,6-dione supplier Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. 5-phenyl-5-propyl-1,3-diazinane-4,6-dione vendor Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. 5-phenyl-5-propyl-1,3-diazinane-4,6-dione factory Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).
